Adel S Lashien (Adel Abdel-Moneim)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Platelet Rich Plasma

Hepatitis C Virus Infection

Combination Therapy

Top Venues

Journal of molecular histology

Hepatology international

Drug development research

Journal of AOAC International

This page only lists publications with an associated author ORCID identifier.

Publications

Fatma Mostafa, Adel S Lashien, Manal Abdul-Hamid, Sanaa R Galaly, Hanaa M Mohamed
Retraction Note: Polydatin and polydatin-loaded chitosan nanoparticles attenuate diabetic cardiomyopathy in rats. Journal of molecular histology (2023)
Fatma Mostafa, Adel S Lashien, Manal Abdul-Hamid, Sanaa R Galaly, Hanaa M Mohamed
Polydatin and polydatin-loaded chitosan nanoparticles attenuate diabetic cardiomyopathy in rats. Journal of molecular histology 52 (2) (2021)
Adel S Lashien, Hanaa Ramadan
Novel strategies to oral delivery of insulin: Current progress of nanocarriers for diabetes management. Drug development research (2021)
Adel S Lashien, Ahmed Hosni
Insights into the possible impact of COVID-19 on the endocrine system. Archives of physiology and biochemistry (2021)
Ahmed Sayed Saad, Mohammed E Draz, Ibrahim A Naguib, Hala E Zaazaa, Adel S Lashien, Fatma F Abdallah
Adoption of Advanced Chemometric Methods for Determination of Pyridoxine HCl, Cyclizine HCl, and Meclizine HCl in Presence of Related Impurities: A Comparative Study. Journal of AOAC International (2021)
Adel S Lashien, Alaa Aboud, Mohamed Abdel-Gabaar, Mohamed I Zanaty, Mohamed Ramadan
Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4. Hepatology international 12 (4) (2018)